Unbiased AI-powered news
17 stories related to this topic, newest first.
New York PostUp to 14 million Medicare recipients who are overweight will be eligible for three GLP-1 medications at a $50 copay under a new pilot program. The Medicare GLP-1 Bridge runs from July 2026 through December 2027 and is separate from standard Part D coverage.
usatoday.comThe medication accumulated one million prescriptions within 12 weeks of U.S. availability and added two million more in the next 10 weeks.
The HillPresident Trump announced the expansion on Friday. The platform now covers four out of five prescriptions filled by Americans and has saved patients more than $400 million.
fastcompany.comMedicare will begin covering Wegovy and Zepbound for weight loss at $50 per month for older adults in July. The agency has not disclosed the projected cost to taxpayers.
usatoday.comThe U.S. Supreme Court declined to review lawsuits filed by six pharmaceutical companies against the Medicare drug price negotiation program. The White House separately announced an expansion of its TrumpRx discount platform through partnerships with three prescription savings se…
rediff.comThe White House expanded its direct-to-consumer drug platform on Monday by adding more than 600 generic medications. The move aims to increase options for cash-paying patients seeking lower prescription prices.
realitytea.comPresident Trump plans to announce an expansion of discounted prescription drug offerings. The program uses Most-Favored-Nation pricing to lower costs for Americans.
ksl.comThe company developed software that automates administrative tasks for prescriptions including insurance routing, prior authorizations and pharmacy selection. It reported reaching a $1 billion valuation with $160 million in total funding and annualized revenue now above $50 milli…
New York PostA study found prescriptions for ivermectin and fenbendazole among cancer patients increased more than 2.5 times in the months after actor-director Mel Gibson discussed the drugs on a January 2025 podcast episode. The combination saw the largest increases among young men, white pa…
gizmodo.comPrescriptions for ivermectin and fenbendazole rose sharply in the months after Mel Gibson told Joe Rogan that the drugs had cured Stage 4 cancer in three of his friends. A study published in JAMA Network Open found the rate of prescriptions among cancer patients more than doubled…
ForbesForus has developed AI software that automates the administrative processing of prescriptions from the moment a physician writes them. The company reported reaching a $1 billion valuation after raising $160 million from investors including Thrive Capital, General Catalyst and Acc…
Beddoe developed insomnia, akathisia and suicidal thoughts shortly after starting sertraline for post-natal exhaustion, leading to multiple additional prescriptions, a bipolar diagnosis and repeated psychiatric admissions. She later tapered off all drugs and regained her mental h…
realclearmarkets.comA KFF poll released May 6 found that 4 in 10 adults who support the MAHA movement identified lowering health care costs, including prescription drugs, as the top health priority for the federal government. This concern outranked restricting chemical additives in food and reevalua…
medium.comJohnson & Johnson will begin marketing four medications on the Trump administration's TrumpRx website on Friday. The move follows a voluntary agreement announced in January that provides Medicaid access to affordable prescriptions in exchange for tariff exemptions. The addition m…
Substrate placeholder — needs reviewBillionaire investor Mark Cuban revealed a partnership with the Trump administration and TrumpRx to lower prescription drug costs. The initiative integrates Cost Plus Drugs' medications into TrumpRx. Cuban emphasized affordability across political lines in a Fox News appearance.
Substrate placeholder — needs reviewThe Maryland Prescription Drug Affordability Board has established an upper payment limit for Jardiance, a type 2 diabetes medicine, capping its price at $204 for a 30-day supply by January 2027. The board will oversee a process to lower costs for state and local governments. The…
Substrate placeholder — needs reviewThe U.S. Food and Drug Administration has declined a request to provide specific guidance on alternative funding programs that import prescription drugs from overseas. These programs connect patients with affordable medications for critical diseases, though regulators state the i…